26-Oct-2026 08:45:10
General news
Nomura on DR Reddys ; Buy, TP Rs 1730
2QFY27: Beat led by cost and mix Company expects EBITDA margin to sustain above 20% Sema relaunch and Abatacept approval key catalysts Stock currently trades at 16x FY29F EPS.
26-Oct-2026 08:45:10
2QFY27: Beat led by cost and mix Company expects EBITDA margin to sustain above 20% Sema relaunch and Abatacept approval key catalysts Stock currently trades at 16x FY29F EPS.